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Mitochondrial nitric oxide in the signaling of cell integrated responses
Maria Cecilia Carreras1,2 and Juan José Poderoso1
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Carreras MC, Poderoso JJ. Mitochondrial nitric oxide in the signaling of
cell-integrated responses. Am J Physiol Cell Physiol 292: C1569–C1580, 2007;
doi:10.1152/ajpcell.00248.2006.—Mitochondria are the specialized organelles for
energy metabolism, but, as a typical example of system biology, they also activate
a multiplicity of pathways that modulate cell proliferation and mitochondrial
biogenesis or oppositely promote cell arrest and programmed cell death by a limited
number of oxidative or nitrosative reactions. These reactions are influenced by
matrix nitric oxide (NO) steady-state concentration, either from local production or
by gas diffusion to mitochondria from the canonical sources. Likewise, in a range
of 30–200 nM, NO turns mitochondrial O2 utilization down by binding to
cytochrome oxidase and elicits a burst of superoxide anion and hydrogen peroxide
that diffuses outside mitochondria. Depending on NO levels and antioxidant
defenses, more or less H2O2 accumulates in cytosol and nucleus, and the resulting
redox grading contributes to dual activation of proliferating and proapoptotic
cascades, like ERK1/2 or p38 MAPK. Moreover, these sequential activating
pathways participate in rat liver and brain development and in thyroid modulation
of mitochondrial metabolism and contribute to hypothyroid phenotype through
complex I nitration. On the contrary, lack of NO disrupts pathways like
S-nitrosylation or H2O2 production and likewise is a gateway to disease in
amyotrophic lateral sclerosis with superoxide dismutase 1 mutations or to cancer
proliferation.
peroxynitrite; hydrogen peroxide; mitochondrial nitric oxide synthase; mitogen-
activated protein kinase
MITOCHONDRIA PLAY A PIVOTAL role in cell physiology, producing
the cellular energy and acting as signaling organelles. A mito-
chondria-based network elicits a multiplicity of effects and re-
sponses, depending on the course of cell life and on the environ-
mental stimuli. This organization resulted from the selective
pressure applied on eukaryotes to evolve the original endosymbi-
ont process between bacteria, i.e., Cyanobacteria sp., and the
primordial prokaryote structure. Accordingly, contribution of mi-
tochondria includes several cohorts of integrated biochemical
pathways shared with nucleus and mainly directed to execute the
different cell programs or with the plasma membrane to elicit the
responses to environmental challenges. Interestingly, mitochon-
drial pathways involve a limited number of reactions; depending
on the steady-state concentrations of substrates and products and
on the rate of oxidative reactions, there exist dual or even opposite
effects on cell responses.
NITRIC OXIDE IN MITOCHONDRIA
Mitochondria are the central organelles in cell bioenergetics.
Most available oxygen is consumed in the electron transfer
chain, placed in the inner membrane of the two membranes that
limit the differentiated mitochondrial compartment. Electron
transfer through mitochondrial complexes I, III, and IV is
joined to proton pumping across the inner membrane, creating
a proton electrochemical gradient between the intermembrane
space and the matrix. The gradient is dissipated by the reentry
of protons through F1F0 ATP synthase channels (complex V),
which couple ATP synthesis to the electron transfer activity.
From a classic perspective, it is accepted that the rate of this
process is regulated by O2 and substrate availabilities as well as
by the ADP-to-ATP ratio, likely the main mitochondrial mod-
ulator in response to cell demands.
During the past years, significant regulatory effects of nitric
oxide (NO) on mitochondrial respiration became evident as re-
sulting from its high-affinity binding to cytochrome oxidase
(COX), the final electron acceptor (19). The synthesis of NO from
L-arginine and O2 is catalyzed by nitric oxide synthases (NOS)
(92). There exist three canonical isoforms [neuronal (NOS I or
nNOS), inducible (NOS II), and endothelial (NOS III)] and a
significant number of spliced and posttranslationally modified
variants. In addition, new isoforms or mitochondrial variants of
NOS (mtNOS) were recently described in rat liver (60, 63),
thymus (29), and brain (119); mtNOS is bound to mitochondrial
PDZ domains of COX (57, 103) and to complex I (57), thus
favoring a steric relationship between the released NO, vectorially
directed to the matrix and inner membrane, and the control of
respiration. In pathological conditions such as extreme hypoxia,
mitochondrial NO could come either from stimulated NOS (116,
142) or from the reduction of nitrite by COX (39).
NOS I and III (45, 82) are constitutively expressed in
different tissues, although their expression is tightly regulated.
These enzymes are bound to anchoring proteins in cell mem-
brane (caveolin) and in synaptic vesicles (PSD95) in skeletal
and cardiac muscles (dystrophin) and to heat shock protein
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(HSP) 90 or 70 chaperones (79). The interaction with these
proteins may involve different effects: 1) increased (HSP90-
NOS) or decreased (caveolin-NOS) enzyme activity, 2) mod-
ified subcellular traffic (dystrophin impedes NOS I traffic to
mitochondria) (76), and 3) participation in ubiquitination and
degradation (54). Constitutive NOS are activated by Ca2
pulses after activation of cell surface receptors by effectors like
bradykinin or acetylcholine (endothelial NOS III) or excitatory
amino acids like glutamate (neuronal synaptic NOS I) (45).
NOS I and III are characterized by fast and transient responses
to facilitate neural transmission or to induce a prompt vasodi-
lation in response to changes in blood flow. In contrast, NOS
II is not constitutive and does not depend on Ca2 concentra-
tion; NOS II gene expression is modulated by inflammatory
mediators, like cytokines TNF-, IFN-, and LPS that activate
transcription factors like NF-B or AP-1 (59). The mtNOS is
nNOS- translocated to mitochondria with specific posttrans-
lational modifications such as myristoylation and phosphory-
lation of Ser-1412 in an Akt-dependent motif (RXRXXS/T); it
is constitutively expressed and Ca2 dependent, and it is
subjected to modulation by drugs or hormones or during
development (21, 32, 34, 119).
The activities of classic NOS isoforms are able to sustain
NO cytosolic concentrations large enough to reach mitochon-
dria. The diffusion coefficient of NO in aqueous solutions is
similar to that of O2, in 4  106 cm2/s (143); activation of
endothelium is compatible with a concentration in the arterial
wall of 2 M NO. Most NO binds to cytosolic compounds, like
myoglobin (35, 111). Therefore, mitochondrial NO coming
from classic cytosolic NOS results in a considerably lower
concentration, 20–100 nM (18, 111); however, it may in-
crease by fivefold after induction of inducible NOS in endo-
toxemia (14). In this condition, both increased NO and NO-
derived superoxide anion (O2
) favor the formation of intrami-
tochondrial peroxynitrite (13).
In addition, new evidence supports the notion that mitochon-
drial NO steady-state concentration is also sustained by the
constitutive activity of mtNOS (64). It is noteworthy that
changes in the expression and activities of NOS isoforms,
particularly of intra-mtNOS, will be followed by significant
variations in NO steady-state levels in the relatively small and
well-differentiated mitochondrial compartment.
OXYGEN AND NO UTILIZATION
In mitochondria, NO acts at different levels. As previously
reported by us and others, in rat heart mitochondria (108),
skeletal muscle, and liver mitochondria (48, 110) and synap-
tosomes (25), NO reversibly binds to Cu2 B center of COX
and consequently inhibits electron transfer to O2 and mitochon-
drial O2 uptake. The same effects were described by our group
in the isolated rat heart (111) and by others in different organs
(78) and in the whole animal, evaluated as systemic oxygen
uptake (130). It is noteworthy that NO-dependent inhibition of
O2 utilization is achieved at very low physiological NO con-
centrations; 50–100 nM NO inhibits by half the activity of
COX (108, 110).
An elegant computational study on mitochondrial NO ef-
fects was done by Antunes et al. (5). The authors simulated
typical NO effects in experiments of inhibition of mitochon-
drial respiration, whereas the rate of O2 utilization was evalu-
ated in a variety of conditions. At steady state and in the
absence of NO, the rate of oxygen consumption predicted by
the utilized model resulted in a hyperbolic function of O2
concentration. The K0.5 value is the O2 concentration ([O2])
that provides the half-maximal rate of O2 uptake (also referred
as KMO2 and [O2]0.5) and indicates apparent affinity of respi-
ration for O2. In this study, K0.5 values for O2 consumption in
states 3 and 4 were 0.22 and 0.022 M, respectively, in
reasonable agreement with the experimental values (0.35–1.7
M in state 3 and 0.08–0.6 M in state 4) (20–65). In
addition, the model predicted that, at the micromolar levels of
oxygen found in tissues, the rate of respiration would be nearly












where brackets indicate concentration, kO2app is apparent
rate of O2 uptake, tot is total, and kIV is the rate of O2
consumption in state 4. With respect to NO inhibitory effects,
the main results obtained by the authors reflected that, at the
same NO concentration, the degree of inhibition increased
when the oxygen concentration decreased and that the degree
of inhibition caused by the same concentrations of NO and O2
was much more pronounced in state 3 than in state 4 (5). NO
inhibited mitochondrial respiration at high ratios (	1,000) of
O2 to NO, and the onset of inhibition was extremely fast,
occurring virtually immediately after NO addition. Therefore,
mathematical calculation results were identical to those ob-
served experimentally (16, 20, 24, 97, 137).
To evaluate whether the fast inhibition of mitochondrial
respiration by NO represents a simple competition between NO
and O2 for COX, the formation of the complex between COX
and NO was followed by the authors after addition of NO. As
observed experimentally (62, 139), the formation of COX-NO
occurred within a few seconds after NO addition. The time
scale for the inhibition of COX by NO is given by kNOon 
[NO]; at typical [NO] 
 108 M, a time scale of 1 s was
obtained, with higher NO concentrations (107 to 106 M)
giving faster inhibitions (110). Therefore, the fast inhibition of
COX by NO is completely compatible with a direct competi-
tion between NO and O2 for COX; at the steady state and in the
presence of NO, the rate of respiration is given by Eq. 2, which
describes a simple linear competitive inhibition of COX by NO
with an inhibition constant (Ki) given by kNOoff/kNOon (kNOon
and kNOoff are defined in supporting material of Ref. 5). Thus














K0.51  [NO]Ki   [O2]
(2)
As stated by Antunes et al. (5), the ratio of the respiration
rate in the absence of NO to the respiration rate in the presence
of NO, deduced by combining Eqs. 1 and 2, is
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[NO]  inhibited respiratory rate
 1 
KNOon [NO]
kNOoff 1  O2 kO2app/kIV
(3)
and the concentration of NO that inhibits mitochondrial respi-






O2  Ki 1  O2K0.5 (4)
These calculations are useful for isolated COX, although
they should be modified to include additional NO effects on
other respiratory components, as occurs in vivo. Accordingly,
NO inhibits COX and increases the reduction levels of the
components of the electron transfer chain, including ubiquinol
and ubisemiquinone, on the substrate side of COX and reacts
directly with ubiquinol to produce nitroxyl anion (NO) and
ubisemiquinone (109, 110). A decade ago, we found that
mitochondrial utilization of NO involves a similar inhibition of
the b-c1 region at complex III that increases the production rate
of O2
 and H2O2 (108, 109). Hence, the reactions of NO with
components or products of the mitochondrial respiratory chain
are, as in bacteria, reductive and yield NO or they are
oxidative and yield ONOO (18).
NO UTILIZATION IS OBLIGATORILY LINKED TO THE
MITOCHONDRIAL PRODUCTION OF OXYGEN
ACTIVE SPECIES
Almost 20 yr ago, Boveris et al. (22) reported that mito-
chondria produce oxygen active species by auto-oxidation of
intermediary ubisemiquinone (UQ), a transitional redox state
of membrane ubiquinol. About 2–3% of utilized O2 undergoes
one-electron reduction by ubisemiquinone forming O2
. In the
presence of mitochondrial manganese superoxide dismutase
(MnSOD), most of O2
 is dismutated to H2O2, which is freely
diffusible to cytosol.
UQH  e ¡ UQ  reaction 1)
UQ   O2 ¡ UQ  O2
  reaction 2)
To sustain this notion, the ubisemiquinone pool and O2
 pro-
duction rate can be experimentally increased by the utilization
of specific compounds like antimycin (complex III inhibitor),
which blocks electron flow between cytochromes b and c (22).
Considering that mitochondrial NO metabolism involves
regulatory aspects on O2 consumption and O2
 and H2O2
production and the resultant effects of freely diffusible H2O2
outside mitochondria on gene expression and cell signaling, it
is surmised that these activities markedly contribute to the
mitochondrial modulation of life processes.
It is remarkable that the enzymes of the electron transfer
chain show a different sensitivity to NO (108). Accordingly, at
0.3–0.5 M, NO inhibits electron transfer between cyto-
chromes b and c1 in the respiratory chain (108, 111), whereas
relatively prolonged 0.5–1 M NO exposure selectively inhib-
its the NADH dehydrogenase activity at mitochondrial com-
plex I in intact cells (50) and isolated mitochondria (120), a
hallmark of neurodegenerative experimental or clinical entities
like Parkinson disease. Finally, albeit controversial, some au-
thors believe NO is able to inhibit complex II activity, which
probably depends on the time of exposure and the type of
utilized mitochondria in the experimental setting (38, 133). As
a consequence of the above-mentioned NO effects, it results in
an increase in the reduction level of the mitochondrial compo-
nents, which, in turn, favors the reaction of NO with ubiquinol
and with complex I components. NO oxidizes ubiquinol with a
second-order reaction rate constant of 2.3  103 M1 s1
(109, 110) to the respective semiquinone (reaction 3), which
decays by auto-oxidation to ubiquinone, forming O2
 (reaction
3 followed by reaction 2).
UQH  NO ¡ NO  UQH  reaction 3)
UQ   O2 ¡ UQ  O2
  reaction 2)
Finally, O2
 reacts with NO to form peroxynitrite anion or
dismutates to H2O2, a reaction catalized by MnSOD (reactions
4 and 5):
O2
   NO ¡ ONOO reaction 4)
O2
   O2
   2HO¡
MnSOD
H2O2  O2 reaction 5)
Considering the reaction rate constants of reactions 4 and 5
[2  1010 and 2.3  109 M1 s1, respectively (56 and 80)],
its relative participation in mitochondrial metabolism will
depend on NO concentration and on MnSOD level. In agree-
ment, supplementation of submitochondrial particles with
complex I or complex II substrates increases by 10- to 20-fold
NO utilization; in contrast, addition of superoxide dismutase
(SOD) decreases NO utilization and prolongs its mean life and
increases H2O2 (110). From these observations, it is notewor-
thy that 1) in mitochondria, most NO decays by reaction 4 and
2) depending on NO and MnSOD concentrations, mitochon-
drial utilization of NO involves the formation of H2O2, a
species freely diffusible outside of mitochondria (30).
From this view, the modulation and activities of NO utili-
zation pathways and mitochondrial NO, superoxide anion,
H2O2, and peroxynitrite yield participate significantly in life
processes. In the past decades, cumulative evidence has shown
that H2O2 and the related oxidative stress level play significant
roles in the activation of signaling pathways to control cell
proliferation, differentiation, apoptosis, and senescence. Fur-
thermore, redox status is clearly related to the activity of
growth factors and to cell transformation and cancer. Our
underlying proposal is that grading expression and activities of
NOS isoforms and the concentration of matrix NO modulate
H2O2 and oxidative stress. As described in cell transformation
(71), concomitant changes in MnSOD have two effects: to
increase cytosolic H2O2 and to prolong NO effects on mito-
chondria. These two effects are the principles of system biol-
ogy that signal for different physiological or pathological
responses.
PRODUCTION AND CELL STEADY STATE CONCENTRATION
OF H2O2
The mitochondrial and cytosolic rates of formation and
utilization of NO and derived oxidants and the calculation of
their cell steady-state concentrations ([NO]ss and [H2O2]ss) are
important because of their impact on cell processes. The
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assessment of steady-state calculations implies the assumption
that, in a determined period of time, the production and
utilization of the compounds are equalized: d[H2O2]/dt 

d[H2O2]/dt and d[NO]/dt 
 d[NO]/dt.
The d[H2O2]/dt is contributed by mitochondria and peroxi-
somes and to a lesser extent by tissue-specific reactions.
Because peroxisomes contain the highest concentration of
catabolizing catalase, mitochondria with very low levels of
degrading enzymes are accepted as the main source of O2
species (17, 33). The dismutation of O2
 to H2O2 entails a
two-electron reductive reaction catalyzed by compartmental-
ized enzyme isoforms. In microsomes, O2
 is dismutated to
H2O2 by Cu/ZnSOD, whereas in mitochondria the reaction is
catalyzed by MnSOD. Otherwise, enzymes that catabolize
H2O2, catalase, gluthatione peroxidase (GPx; reactions 6 and
7), and thioredoxin peroxidase (Trx; reaction 8) are preferen-
tially distributed in cytosol and peroxisomes.
H2O2  H2O2O¡
Catalase
2H2O  O2 reaction 6)
H2O2  2GSHO¡
GPx
2H2O  GSSG reaction 7)
Trx(SH)2  ROOHO¡
TPx
TrxS2  ROH  H2O reaction 8)
H2O2 is freely diffusible through cell membranes, and thus
a similar mitochondrial and cytosolic [H2O2]ss should be ex-
pected. In agreement, [H2O2]ss has been calculated as 108
to 109 M in rat liver cytosol (40), rat liver mitochondria (40),
and stimulated perfused liver (27), as well as after diffusion in
hepatocytes (141). Thus cell or tissue [H2O2]ss could be cal-
culated as the ratio between H2O2 mitochondrial yield and the
catabolizing cytosolic enzyme activities.
In rat liver mitochondria, the physiological [NO]ss levels
have been estimated to be 0.5–1  107 M (18, 111). At
physiological or even lower O2 levels, it should be reasonable
to expect less O2
 production because O2 uptake and electron
transfer are proportionally lower. However, experimentally,
the O2
 production in living tissues at 5–10 M O2 is not far
from that at the atmospheric level (12, 40).
At 0.1 M NO, d[H2O2]/dt is 0.8  106 M/s. Consid-
ering the reduction to H2O by liver cytosolic GPx and catalase
at the respective concentrations of 2.7  106 M and 1.2 
106 M and the rate constants for reactions 7 and 8, the





0.8  106 M1  s1
5  107 M1 s12.7  106 M





Previous references indicated that, in liver, cytosolic
[H2O2]ss 
 0.8  108 M (17); on the basis of experimental
data and of the present calculations, H2O2 generated physio-
logically after NO mitochondrial utilization in liver accounts
for one-half of its cytosolic concentration. These data empha-
size the importance of mitochondrial NO metabolism in the
generation of oxygen active species, particularly at near-phys-
iological NO concentrations.
On these bases, the modulation of [H2O2]ss implies an
effective regulation of the different pathways participating in
the process, including the concentration and activities of mt-
NOS, cytosolic classic NOS isoforms, MnSOD, catalase, and
peroxidases. Thus most of the experimental evidence is based
on manipulation of the related enzymes, either by disruption of
specific genes, by transfection of encoding cDNA, or just by
addition or subtraction of antioxidant enzymes, like catalase.
MITOCHONDRIAL NO AND REDOX METABOLISM ARE
DETERMINANTS OF CELL DECISION CONCERNING
PROLIFERATION OR CELL CYCLE ARREST
Although high levels of reactive oxygen species (ROS) are
frequently associated with cytotoxicity, H2O2 mediates the
transmission of many intracellular signals, including those
related to growth and transformation. Hence, proliferating
mammalian cells have different responses to oxidative stress,
likewise depending on the stress level (52). Those grading
effects of H2O2 have been reported by Antunes and Cadenas
(4) in Jurkat T cells. Although the authors did not explore the
proliferative phase, in these cells, very low (0.7 M) H2O2
steady-state concentration represented the edge between sur-
vival and apoptosis, a level completely in line with that
measured in different cell lines and tissues (17). It is notewor-
thy that after “in vitro” supplementation of exogenous H2O2 to
cell cultures, antioxidant enzymes will set the [H2O2]ss to a
considerably lower value in the intracellular milieu. In agree-
ment and at a similar H2O2 concentration (1 M), we observed
an increase of the proliferation rate of PO7 lung tumor cells
(58). In the same way and considering oncogenic transforma-
tion as a state of uncontrolled proliferation with no differenti-
ation, H2O2 and oxidative stress have been accepted to have a
major role (74, 135, 136). In an elegant study, Arnold et al. (7)
showed that transfection of oxidase Nox1 to NIH/3T3 fibro-
blasts, which increases cell H2O2 levels by fivefold, resulted in
a transformed phenotype with aggressive tumor formation. In
this study, cells were reverted to a normal phenotype by
cotransfection with catalase, and the authors concluded that a
major role of H2O2 is to activate genes related to the prolifer-
ating cascade.
On the other hand, high H2O2 concentration (100–200 M)
induces temporary cell cycle arrest followed by overexpression
of genes encoding antioxidant and protective enzymes in fi-
broblasts (113, 114). Even at higher concentrations (250–400
M), H2O2 induces an almost permanent growth-arrested state
but without cell damage.
Therefore, the progression of NO and H2O2 effects from
proliferation to cell cycle arrest and differentiation arises in
differential effects elicited by low and high cellular concentra-
tions to related effects, such as 1) kinase activation or inhibi-
tion (112), 2) effects on cyclins (37), and 3) Ca2 release (90).
It is noteworthy that effects of NO and H2O2 are confluent
on modulation of MAPKs and cyclin D1. MAPKs, including
SAPK/JNK, p38 MAPK, and ERK, are believed to be redox-
dependent biomolecules that modulate cell proliferation, sur-
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vival, and apoptosis (41). ERKs stimulate cell proliferation and
induction of active cyclin D1 by different mechanisms, includ-
ing the enhancement of AP-1 activity. In the same way, NO
determines a gradual, moderate elevation of intracellular
[Ca2] and leads to activation of ERKs and potentiates cell
division; functionally blocking Ca2 or inhibiting calmodulin
or MAPK activities prevents ERK activation and antagonizes
the mitogenic effect of NO (90). On the other hand, p38 SAPK
transcriptionally downregulates cyclin D1. Casanovas et al.
(37) reported that oxidative and osmotic stresses decrease
cyclin D1 activity and expression, the former by activating p38
pathway (37). This effect is due to phosphorylation of cyclin
D1 at Thr-286, which leads to the ubiquitination of the enzyme.
The same effects were observed by Awad and Grappuso (8)
who reported a temporal inverse correlation between activation
of p38 MAPK and cyclin D1 content during liver development
or liver regeneration in the rat. Similarly, NO activates p38
MAPK and suppresses proliferation through the activation of
JAK2-STAT5 and cyclin D1/cdk4 (70). In accordance, the
responses to shear stress of cultured microvascular endothelial
cells are mediated by signal pathways involving both produc-
tion of NO and activation of p38 MAPK pathway (93).
Considering the occurrence of reactions 2–5 in mitochon-
dria, previously, our group (32, 57) attempted to connect
oxidative stress and NO levels to MAPKs, D cyclins, and cell
proliferation. Our studies confirmed that NO yield and the
oxidative stress level modulate the different cell responses.
Both H2O2 and NO react with thiol groups of cysteine,
methionine, or another amino acids that may modify the
activity of tyrosine kinases, tyrosine phosphatases, and other
proteins (10, 140). Another mechanism is the activation of
specific phosphorylation cascades that participate in the pro-
gression of the cell cycle; for instance, H2O2 acts as a mes-
senger in growth factor-induced p70(S6k) signaling pathway in
mouse epidermal cells, which plays an important role in the
transition from G0/G1 to S phase of the cell cycle (9). Finally,
our group (2) observed ERK1/2 activation in brain mitochon-
dria by very low concentrations of H2O2 (0.1 M) but kinase
inhibition when cells or isolated organelles were exposed to
higher H2O2 concentrations (1–10 M). It is not clear whether
it implies a direct redox effect on the protein or actions on
ERK-MEK (MAPK kinase) interactions. In this way, it was
proposed that duration of MAPK activation determines
whether a stimulus produces proliferation or differentiation
(69). Activation of a myeloid leukemia cell line (TF-1a) by
granulocyte/macrophage colony-stimulating factor induced
only a transient activation of MEK and ERK1/2 and 50%
increase in cell proliferation, whereas prolonged stimulation
with 108 to 106 M PMA underwent 91–98% cell differen-
tiation without proliferation. The findings gain significance
considering that ERK1/2 are activated by ROS (134).
Antiproliferative effects are related to suppression of growth
signals or potentiation of inhibitory signals and to resulting
changes in cell cycle regulators such as p21, p27, cyclins, and
retinoblastoma protein. The proapoptotic effects depend on
translocation of Bax to mitochondria and generation of ROS
and ultimately on the release of cytochrome c but in a caspase-
independent manner. For instance, activation of p38 MAPK
and cell cycle arrest may finally progress to apoptosis in the
presence of NO, which may activate the p38 MAPK pathway.
In accord, the p38 inhibitor SB-203580 blocks proapoptotic
effects of NO in SH-SY5Y neurons (94). The activating NO
effects and p38 MAPK signaling probably result in Bax trans-
location to mitochondria, a well-known constituent of pro-
grammed cell death (61). Kurata (81) reported that low oxida-
tive stress (20 M H2O2) causes a rapid activation of p38
MAPK cascade, with phosphorylation of MKK3/6 and p38
MAPK and activating transcription factors (ATF)-1 (cAMP
response element-binding protein) and ATF-2. These effects
were associated with mitotic arrest and inhibition of cell
division in phase M of the cell cycle during 24 h and were
cancelled by N-acetylcysteine or SB-203580, a specific p38
MAPK inhibitor. Similar effects were described by Sahl et al.
(125) who observed that H2O2-induced cellular injury depends
on JNK activation. In this case, also p38 and ERK were
activated by H2O2; however, only JNK-related injuring effects
were inhibited by the MEK inhibitor PD-98059. Moreover,
JNK phosphorylation of p53 is important for the stabilization
of proapoptotic p53 protein (28). Early activation of p38
MAPK and ERK does not seem to be dependent on cytotoxic
factors like intracellular Ca2 movements. These results sug-
gest that physiological H2O2-dependent activation of p38
MAPK may proceed many steps before a significant Ca2
release from intracellular and mitochondrial stores and that
Ca2-dependent tyrosine kinase-induced activation of SAPK/
JNK reflects the progression of cell injury (73).
NITRATION AND NITROSYLATION OF MITOCHONDRIAL
COMPONENTS: THE THYROID MODEL
Depending on the antioxidant levels, the consequence of
high matrix [NO]ss is that nitrosative and nitrative (and oxida-
tive) reactions are magnified in mitochondria. The main mito-
chondrial antioxidant defense is MnSOD. At the same SOD
level, the production of ONOO (and concurrent nitration) at
0.02 or 0.2 M NO will be completely different. Dismutation
of O2
 by SOD proceeds with an order of magnitude lower than
formation of peroxynitrite (109 vs. 1010 M1 s1) (80); thus it
may hardly compete with ONOO formation at high NO
levels.
NO has both pro- and antiapoptotic effects. Some antiapop-
totic effects include S-nitrosylation and inhibition of caspases,
increase of HSPs and Bcl-2, and activation of Akt/PKB, which
induces cytoprotective gene expression through NF-B activa-
tion (85). S-nitrosylation is the modification of critical cysteine
residues on proteins; dysregulation of this process by increased
NO production has been linked to pathophysiology (86). Ac-
cordingly, endogenous NO production inhibits apoptosis of
pulmonary epithelial cells in culture (75) and the apoptosis
induced by bleomycin (53, 124); inhaled NO protects against
apoptosis after hyperoxia (68) or ischemia-reperfusion injury
(145). On the other hand, proapoptotic effects of NO include
inhibition of NF-B, decreased Bcl-2 expression (87–89, 118),
and increased p53 expression, both by NO-mediated inhibition
of proteasome degradation and by direct DNA damage.
Recent reported data suggest that excessive NO production
and protein S-nitrosylation may contribute to disease. For
instance, the E3 ligase parkin is aberrantly S-nitrosylated
because of increased NO production in Parkinson disease (47,
146). S-nitrosylation inhibits parkin activity, leading to the
accumulation of misfolded proteins and to abnormal aggrega-
Invited Review
C1573MITOCHONDRIAL NO AND CELL-INTEGRATED RESPONSES
AJP-Cell Physiol • VOL 292 • MAY 2007 • www.ajpcell.org
 on M






tion as Lewy bodies, which contribute to apoptosis of dopa-
minergic neurons.
On the other hand, as referred in reaction 4, nitration on
tyrosine, cysteine, or tryptophan follows the formation of
peroxynitrite or protein exposure to NO2; ONOO-dependent
tyrosine nitration is a radical-radical reaction between tyrosyl
and caged distributed NO2 and OH (129).
In mitochondria, most of O2
 formation occurs in complexes
III and I; however, other mitochondrial enzymes, like mono-
amino oxidase, could contribute to ROS production (3). Thus,
at high NO, ONOO formation is expected to specially pro-
ceed in those localizations. Clementi et al. (49) reported com-
plex I inhibition in intact macrophages exposed to an NO
donor, and we subsequently confirmed complex I inhibition
and protein nitration in intact brain and liver mitochondria
exposed to NO in a prolonged fashion. The inhibition of
complex I limits the flow of electrons from NADH to the
ubiquinol pool and markedly increases the O2
 yield (36).
However, it has been reported that, in intact mitochondria,
rotenone inhibition of complex I did not increase ROS produc-
tion with complex I substrates in myocardial ischemia (43).
Similar to the NADH dehydrogenase site of electron leak
forming complex I being directed into the matrix side of the
inner mitochondrial membrane, in mitochondria, O2
 can be
detoxified by matrix antioxidant defense systems. Therefore,
ROS production may differ substantially in mitochondria and
corresponding submitochondrial particles that do not contain
antioxidant enzymes.
To clearly exemplify mitochondrial effects of NO and the
subsequent cohort of effects, we studied the hypothyroid con-
dition. Thyroid status is crucial for energy homeostasis, and its
physiological roles in growth and in organ and cell differenti-
ation have been extensively studied. Thyroid hormone effects
are exerted on mitochondria of specific target tissues like liver
and skeletal muscle, whereas oxidative metabolism of other
organs like brain is not affected (117). The action of thyroid
hormone on respiratory functions has been considered to be
operating at two levels: by altering mitochondrial inner mem-
brane composition and permeability and by influencing respi-
ratory gene expression. Thyroid status affects simultaneously
the mitochondrial cytochrome content; in particular, cyto-
chrome aa3 is strongly affected because it decreases by 80% in
hypothyroidism, whereas it increases by 130% in hyperthy-
roidism (99). Changes in properties and composition of mito-
chondrial membranes, particularly in cardiolipin content, lead
to variations of redox enzyme activities (72, 126) and in proton
leak (23). However, although direct or transcriptional effects
have considerable impact on oxidative metabolism, it is not
defined how thyroid hormones set body metabolic rate. Con-
sidering NO effects on O2 uptake, we analyzed the effects of
thyroid status on mtNOS content (34, 57). At low levels of
3,3,5-triiodothyronine (T3) in hypothyroidism, nNOS mRNA
increased by threefold and nNOS translocation to mitochondria
was favored with concomitant increase of mtNOS expression
and activity. Two effects emerged from nNOS confinement.
First, decreased O2 consumption was more sensitive to L-
arginine and to the NOS inhibitor NG-monomethyl-L-arginine,
indicating the modulation of O2 uptake by mtNOS. Second,
high matrix NO resulted in high O2
 and H2O2 yields and to
formation of peroxynitrite. Mitochondrial redox contribution to
the activation of MAPK cascades was also confirmed in the
hypothyroid model. Low T3-dependent mtNOS activation re-
sulted in high oxidant production (H2O2 and peroxynitrite),
with the concomitant activation of p38 MAPK and the inacti-
vation of ERK1/2. As shown before, this MAPK pattern is
consistent with cell cycle arrest and inhibition of cell prolifer-
ation, a hallmark of hypothyroidism. A similar effect of a NOS
inhibitor [N-nitro-L-arginine methyl ester (L-NAME)] or T3
replacement in tuning hypothyroid cell signaling back to con-
trol status indicates that differential MAPK activation and
cyclin D1 expression should not depend on thyroid hormone
themselves but on the relative production of mitochondrial
oxidants, NO and peroxynitrite, at the different T3 levels.
In addition, an extensive nitration of mitochondrial complex
I proteins in this model (36, 57) was associated with a mark-
edly reduced rate of electron transfer to ubiquinol acceptor,
contributing to perpetuation of the process (Fig. 1) (57). Com-
plex I derangement and decreased basal metabolic rate were
reverted by previous administration of L-NAME to the hypo-
thyroid rats. These findings suggest that most of O2 consump-
tion inhibition in hypothyroidism is the consequence of com-
plex I inhibition by NO-ONOO overproduced by increased
Fig. 1. Transcriptional increase of neuronal nitric
oxide synthase (nNOS) determines extensive
binding to complex I and IV and contributes to
hypothyroid phenotype. At low 3,3,5-triiodothy-
ronine (T3) levels, there is increased nNOS tran-
scription, translation, and translocation into mito-
chondria, resulting in high mitochondrial NOS
(mtNOS) activity and increased nitric oxide (NO),
ONOO, and H2O2 levels, nitration of mitochon-
drial proteins, and inhibition of complex I and IV.
Top left: nitration of components of mitochondrial
complex I from control, hyper-, and hypothyroid
rat livers. MW, molecular weight; MnSOD, man-
ganese superoxide dismutase; 2D, two dimen-
sional.
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translocated nNOS (mtNOS). It is interesting that lack of T3
stimulates nNOS gene expression, suggesting the existence of
a tonic gene inhibition relying on effects of T3 receptor dimers
on the transcriptional machinery.
MITOCHONDRIA, CELL PROGRAMMED PROLIFERATION,
AND NORMAL DEVELOPMENT
Cell proliferation is a complex programmed process re-
sponding to internal and periodical stimuli, to environmental
ones, or both. Typically, growth factors elicit a cascade of
events, including activation of kinases and transcription fac-
tors, that ultimately act on gene modulation by interacting with
promoters or by increasing expression or activities of co- or
transactivators and co- or transrepressors. To stimulate cell
cycle transition from G0 resting state to G1 check point, cyclins
are phosphorylated by cdk kinases (105, 131). Cyclin D1 is
implicated in the control of G1 phase progression in hepato-
cytes and other proliferating cell types, and its expression is
positively regulated by the ERK pathway and antagonized by
stress-activated p38 MAPK cascade (84). During liver devel-
opment, cyclin D1 content is inversely related to p38 MAPK
activity, which in turn may be regulated by ROS (81) and NO
(104). NO may modulate per se the expression of cell cycle
regulatory proteins (138); NO induces cytostasis by inhibition
of cyclin D1 or by inhibition of cdc2 (cyclin E and A pathways)
(104). In accord, NO has antimitogenic effects on cultured
hepatocytes (51).
During rat liver development, we observed that modulation
of mtNOS and subsequent redox changes regulate MAPK
cascades and cell cycle regulatory proteins in the sequence of
proliferating to quiescent cell stages (Fig. 2) (32). Proliferating
phenotypes were characterized by very low levels of mtNOS
activity and expression, with a resulting NO-dependent
[H2O2]ss of 1011 to 1012 M, and high cyclin D1 expression
associated with high ERK1/2 and low p38 MAPK activities.
On the contrary, quiescent phenotypes presented an opposite
pattern with NO-dependent [H2O2]ss of 109 M. These
differences are enhanced by the lower mitochondrial number
per gram of liver tissue in proliferating tissues and paralleled
the lower content of respiratory complexes and of antioxidant
enzyme activities.
Similar effects of changes in [NO]ss and [H2O2]ss were
observed in cell culture. Isolated neonatal hepatocytes supple-
mented with H2O2, catalase inhibitor 3-amino-1,2,4-triazole, or
L-arginine invariably determined a dose-dependent negative
modulation of cell proliferation. In contrast, decreasing cell
H2O2 levels by controlled treatment with scavengers or NOS
inhibitors, like N-acetylcysteine, glutathione, or L-NAME, in-
creased proliferation rate up to 30%. Moreover, isolated hepa-
tocyte proliferation rate may be modulated by MAPK inhibi-
tors or stimulators like U-0126 (MEK inhibitor), SB-202190
(p38 inhibitor), or anisomycin (p38 activator), suggesting that
hepatocyte proliferation signaling is related to a fine tuning of
H2O2 level in the different developmental stages.
In this context, the synchronized increases of mitochondrial
activities, mtNOS, and [H2O2]ss operate on the balance of
signaling pathways to drive the transition from proliferation to
quiescence in rat liver development. In the same way, we
recently reported that a critical reduction of mtNOS activity
and [H2O2]ss contribute to tumor-persistent (“embryonic”) be-
havior (58).
On the other side, an increase of mtNOS and H2O2 follows
rat brain and cerebellum development, at the phase of synaptic
plasticity (119). High mitochondrial NO and H2O2 yields are
detectable over the last days of pregnancy and persist for
10–12 days after delivery and for up to 20 days in cerebel-
lum, with prolonged plasticity. This mitochondrial response is
consistent with the arrest of neuroblast proliferation and with
apoptosis, the two components of structural synaptic plasticity.
Neurite growth and connection are the bases for the integration
and differentiation of the neural anatomical network; however,
Fig. 2. Scheme of mitochondrial signals at
two NO levels in the modulation of cell
responses during development. In the prolif-
erative stage, low NO and H2O2 levels acti-
vate ERK1/2, resulting in cyclin D1-increased
expression and proliferation. In the quiescent
stage, higher NO, ONOO, and H2O2 levels
activate p38 MAPK, which regulates cyclin
D1 expression, negatively resulting in cell
cycle arrest. Representative Western blot of
cyclin D1 and MAPKs in tumoral cells (P07)
and in lysates of postnatal day 2 (P2) and day
90 (P90) rat liver are included. p, Phosphor-
ylated.
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apoptosis of nonconnected neurons is essential for this pur-
pose.
NO, H2O2, AND CELL APOPTOSIS
In the past decades, one of the more fascinating events was
the discovery of programmed cell death or apoptosis. The
discovery of diverse apoptosis pathways involving signals
primarily via the death receptors (extrinsic pathway) or the
mitochondria (intrinsic pathway) using caspases as effector
molecules has dominated the field. Caspases are cysteine
proteases that cleave specific aspartate residues in other regu-
latory proteins like Bcl-2, Bax, and MEKK (for review, see
Ref. 83). In the extrinsic pathway, binding of membrane
ligands like TNF- and Fas to membrane receptors triggers the
activation of caspases and the induction of apoptosis (6, 106).
In the intrinsic program, mitochondrial damage results in the
release of cytochrome c, triggering the assembly of the apop-
tosome complex with apoptotic protease-activating factor-1 as
central scaffold protein that directly recruits caspase 9, which
in turn elicits caspase 3 effects (31).
It is noteworthy that mitochondria are clearly involved in the
process of programmed cell death. Different agents that pro-
mote apoptosis are associated with mitochondrial changes. For
instance, proapoptotic p53 protein induces gene transcription
of redox-related genes encoding proteins that lead to oxidative
stress (66). In addition, the increase of intracellular Ca2 levels
consecutive to cell injury or dysfunction may open the mito-
chondrial pore transition and drastically inhibit oxidative phos-
phorylation (107). The effects of oxidants may rely on the
potential changes in thiol groups of caspases.
Oxygen active species and NO are now recognized as
important regulators of apoptotic pathways (55, 66, 121).
Proapoptotic activities of NO have been demonstrated in dif-
ferent cells and tissues (1, 46). NO can directly induce cyto-
chrome c release through mitochondrial membrane potential
loss (46) or by tyrosine nitration of cytochrome c (67). NO
donors or endogenous NO induces apoptotic cell death with the
activation of JNK/SAPK and p38 MAPK and caspase 3 or
inactivation of NF-B. In this way, increased inducible NOS
expression and NO production act as a negative regulatory
feedback modulator of NF-B activity (102).
The stimulation or inhibition of NF-B may be related to
proliferative or apoptotic effects. NF-B is activated by several
agents, including cytokines, oxidant free radicals, inhaled par-
ticles, ultraviolet irradiation, and bacterial or viral products
(42). Inappropriate activation of NF-B has been linked to
inflammatory events associated with autoimmune arthritis,
asthma, septic shock, lung fibrosis, glomerulonephritis, athero-
sclerosis, and acquired immunodeficiency syndrome. In con-
trast, complete and persistent inhibition of NF-B has been
linked directly to apoptosis, inappropriate immune cell devel-
opment, and delayed cell growth. Disruption of the NF-B
gene is associated with embryo lethality; many antiapoptotic
pathways like Bcl-2 are induced by NF-B. Accordingly, new
therapeutic strategies have been developed in cancer treatment,
including inhibition of the NF-B pathway (144).
Many proapoptotic effects of NO may be mediated by
peroxynitrite as a by-product of NO and mitochondrial-derived
O2
 (15, 108) (Fig. 3). Cytotoxic effects of NO and peroxyni-
trite on tumor cells have been shown to be the result of DNA
damage, which induces the accumulation of p53. NO-mediated
p53 accumulation induces cell cycle arrest by p21 upregulation
or apoptosis by increase in Bax/Bcl-xL, cytochrome c release,
and caspase activation (100). Moreover, induction of apoptosis
may require the fine biochemical interplay between oxygen and
nitrogen species (99); the mechanism could be important in the
step control and elimination of transformed cells (11).
On the other hand, NO has antiapoptotic effects that can be
associated with cGMP production, which suppresses mito-
chondrial cytochrome c release, ceramide generation, and
caspase activation (46, 77). Other antiapoptotic NO pathways
include S-nitrosylation and inactivation of caspases thiols and
upregulation of antiapoptotic genes like that of heme oxygen-
ase (127) and Hsp70, which protects hepatocytes from apop-
tosis induced by oxidative and nitrative stress (46).
Fig. 3. NO and H2O2 release and activation of intrinsic
programmed cell death via apoptotic protease-activating
factor-1 and activation of p53. Increased NO and ONOO
result in DNA damage, p53 accumulation, increased Bax/
Bcl-2, cytochrome c (cyt c) release, and caspase activation.
Bottom: representative histograms of apoptosis with pro-
pidium iodide of NIH/3T3 cells with and without exposure
to 250 M H2O2 for 24 h.
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THE LACK OF CELL AND MITOCHONDRIAL NO: A NEW
GATEWAY TO PATHOLOGY
Deficient S-nitrosylation has also been linked to disease
pathogenesis (128). Specifically, increased activity of the de-
nitrosylase S-nitrosoglutathione reductase in asthmatic lungs
depletes levels of the endogenous bronchodilator S-nitrosoglu-
tathione, leading to airway hyperresponsiveness (115). Like-
wise, in sickle cell anemia, the sickle cell hemoglobin is
deficient in the intramolecular and intermolecular transfer of
NO moieties. Consequently, red blood cell membrane S-nitro-
sothiol levels are decreased and hypoxic vasodilation is im-
paired, leading to vasoocclusion in hypoxic tissue (101).
Recently, it was reported that deficient protein S-nitrosyla-
tion contributes to the development of amyotrophic lateral
sclerosis (ALS); ALS is one of the most common adult-onset
neurodegenerative diseases and is characterized by degenera-
tion of motoneurons in the spinal cord, brain stem, and cortex
(26), and 10–20% of cases are due to mutations in the SOD1
gene (122, 123). Considering that SOD1 mutations lead to an
increase of the denitrosylase activity of the enzyme, the authors
found that deficient S-nitrosylation can disrupt the functions of
proteins that are regulated by this mechanism (like GAPDH)
and that increased denitrosylase activity is a toxic gain of
function of SOD1 mutants.
In the same way but close to the mitochondrial field, we
previously reported the existence of defective NOS and mt-
NOS in mitochondria from tumor cells (58). Low NO levels
were associated with low H2O2 yields, high proliferation rate,
and activation of ERK1/2, a pattern resembling that shown in
embryonic development (32, 44). Because proapoptotic p38
or JNK1/2 did not become phosphorylated, we surmise the
results are part of the “reciprocal dance between cancer and
fetal development.” In addition, different cell lines normally
underwent proliferation arrest when supplemented with 10 M
H2O2 (52).
CONCLUDING REMARKS
Many years ago, we proposed that, depending on matrix
concentration, NO is utilized in mitochondria with formation
of H2O2 or peroxynitrite (108). Altogether, these species in-
duce profound changes in normal or pathological cell pro-
cesses. A moderately low level of these mitochondrial activi-
ties is compatible with proliferation and mitochondrial biogen-
esis (95, 98); accordingly, stem proliferating cells have a low
number of mitochondria, with resultant low [H2O2]ss. Also,
embryonic and tumor cells share a distinctive pattern charac-
terized by low mitochondrial and cell NO and H2O2 yields. A
controlled decrease of mitochondrial respiration accompanies
proliferation and tumor behavior (132). Likewise and depend-
ing on state 3-to-state 4 O2 uptake ratios and ATP and nucle-
otide demands, control of cell proliferation by mitochondrial
respiration acts by setting [H2O2]ss with differential activation
of MAPKs, Akt, and cyclin D. In this sense, very low NO
inhibits COX and determines low H2O2 yield. Otherwise,
selective and persistent high NO yields block complexes I, II,
and III and further increase active species production in those
sites and associates with cell arrest and/or with activation of the
proapoptotic pathways. Interestingly, selective nitration of
complex I components (57) could determine the final pheno-
type in some conditions, like hypothyroidism. On the other
hand, lack of mitochondrial NO drives mitochondria and cells
to deregulate modulation of metabolism by S-nitrosylation or
to restrain H2O2 increase, leading to the onset of diseases with
high mortality rate, like ALS or cancer.
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